ABG Innovation Capital Partners III GP as of June 30, 2021
Portfolio Holdings for ABG Innovation Capital Partners III GP
ABG Innovation Capital Partners III GP holds 7 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Atea Pharmaceuticals (AVIR) | 91.0 | $27M | 1.3M | 21.48 | |
| Genocea Biosciences Com New (GNCAQ) | 2.9 | $878k | 375k | 2.34 | |
| Synlogic | 2.7 | $801k | 206k | 3.89 | |
| Aerpio Pharmaceuticals | 2.3 | $676k | 400k | 1.69 | |
| Pulmonx Corp (LUNG) | 0.7 | $199k | 4.5k | 44.02 | |
| Idera Pharmaceuticals Com Par | 0.2 | $68k | 56k | 1.21 | |
| Nabriva Therapeutics SHS | 0.2 | $62k | 46k | 1.35 |
